Protalix BioTherapeutics (PLX) EBIT (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Protalix BioTherapeutics | 164.49 Mn | 153.70 Mn | 29.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6,393.45% |
| Dec 31, 2025 | -115.77% |
| Sep 30, 2025 | 81.83% |
| Jun 30, 2025 | 128.28% |
| Mar 31, 2025 | -157.50% |
| Dec 31, 2024 | 80.63% |
| Sep 30, 2024 | 264.44% |
| Jun 30, 2024 | 50.02% |
| Mar 31, 2024 | 13.52% |
| Dec 31, 2023 | -197.56% |
| Sep 30, 2023 | -109.24% |
| Jun 30, 2023 | 930.46% |
| Mar 31, 2023 | -132.80% |
| Dec 31, 2022 | 339.87% |
| Sep 30, 2022 | 43.43% |
| Jun 30, 2022 | -195.40% |
| Mar 31, 2022 | 67.23% |
| Dec 31, 2021 | -202.71% |
| Sep 30, 2021 | 79.43% |
| Jun 30, 2021 | -147.40% |
| Mar 31, 2021 | -230.50% |
| Dec 31, 2020 | 209.95% |
| Sep 30, 2020 | -15.27% |
| Jun 30, 2020 | -147.73% |
| Mar 31, 2020 | 113.32% |
| Dec 31, 2019 | 242.49% |
| Sep 30, 2019 | 73.56% |
| Jun 30, 2019 | -5.51% |
| Mar 31, 2019 | -50.71% |
| Dec 31, 2018 | 1.84% |
| Sep 30, 2018 | 44.53% |
| Jun 30, 2018 | -30.93% |
| Mar 31, 2018 | 46.24% |
| Dec 31, 2017 | -23.40% |
| Sep 30, 2017 | 28.14% |
| Jun 30, 2017 | -69.76% |
| Mar 31, 2017 | 27.01% |
| Dec 31, 2016 | -31.17% |
| Sep 30, 2016 | 33.06% |
| Jun 30, 2016 | -26.28% |
| Mar 31, 2016 | -2.13% |
| Dec 31, 2015 | -53.94% |
| Sep 30, 2015 | 10.42% |
| Jun 30, 2015 | -3.71% |
| Mar 31, 2014 | 62.16% |
| Dec 31, 2013 | -202.83% |
| Sep 30, 2013 | 18.12% |
| Jun 30, 2013 | -55.66% |
| Mar 31, 2013 | 56.44% |
| Dec 31, 2012 | -82.86% |
| Sep 30, 2012 | -157.80% |
| Jun 30, 2012 | 258.62% |
| Mar 31, 2012 | 31.53% |
| Dec 31, 2011 | -1.04% |
| Sep 30, 2011 | 36.78% |
| Jun 30, 2011 | -175.27% |
| Mar 31, 2011 | 43.06% |
| Dec 31, 2010 | -210.67% |
| Sep 30, 2010 | 71.94% |